Finally, using primary cells and stable cell lines, we demonstrate that MARCH2 inhibits HIV-1 infection in a T cell-specific manner, reducing cell-to-cell transmission of HIV-1, while it has no antiviral effect in MDMs. Here, MARCHF2 is linked to HIV-1 infection.